Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus butorphanol for postoperative analgesia after cesarean section
ChiCTR2100054435Phase 4Recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoint: Pressing times of 24h analgesic pump. Started Jul 2021; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100054435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054435.